<SEC-DOCUMENT>0001680367-21-000035.txt : 20210811
<SEC-HEADER>0001680367-21-000035.hdr.sgml : 20210811
<ACCEPTANCE-DATETIME>20210811163136
ACCESSION NUMBER:		0001680367-21-000035
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210811
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210811
DATE AS OF CHANGE:		20210811

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Shattuck Labs, Inc.
		CENTRAL INDEX KEY:			0001680367
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				812575858
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39593
		FILM NUMBER:		211163870

	BUSINESS ADDRESS:	
		STREET 1:		1018 W. 11TH STREET
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78703
		BUSINESS PHONE:		919-864-2700

	MAIL ADDRESS:	
		STREET 1:		1018 W. 11TH STREET
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>sttk-20210811.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:f578a81e-7792-4eab-9554-4c47e1dcf5d1,g:2d6d3d14-999c-41d9-b62c-116f2fa9b40b,d:5212526f9d574edfaa944f3d905e2ff1--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sttk-20210811</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV80L2ZyYWc6MjAwNTdmYzJhYTEyNDVjNmE0YzZlYzI4YzFkMWNmMmQvdGFibGU6M2NhOGM0MmUwNjhiNDBlN2JjODQ3ODAxMmVkODczYzkvdGFibGVyYW5nZTozY2E4YzQyZTA2OGI0MGU3YmM4NDc4MDEyZWQ4NzNjOV8wLTEtMS0xLTA_bc653764-7349-4eb5-b104-a163a1fc4c5b">0001680367</ix:nonNumeric><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV80L2ZyYWc6MjAwNTdmYzJhYTEyNDVjNmE0YzZlYzI4YzFkMWNmMmQvdGFibGU6M2NhOGM0MmUwNjhiNDBlN2JjODQ3ODAxMmVkODczYzkvdGFibGVyYW5nZTozY2E4YzQyZTA2OGI0MGU3YmM4NDc4MDEyZWQ4NzNjOV8xLTEtMS0xLTA_7e0911ac-c54d-424d-9bf5-3d35556c8d47">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sttk-20210811.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001680367</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-11</xbrli:startDate><xbrli:endDate>2021-08-11</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5212526f9d574edfaa944f3d905e2ff1_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:99%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:99%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.5pt;font-weight:700;line-height:99%">WASHINGTON, DC 20549 </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14.5pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81ODI_6658cf96-9158-460b-9e84-436f78ae5f59">8-K</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:99%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:99%">of the Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:99%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV8yMjU_bdac7918-b75e-45f1-bcdf-5809f6243250">August 11, 2021</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.198%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20.5pt;font-weight:700;line-height:99%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81NjY_e5d97022-03e0-4349-a1b1-5ec0f6589043">Shattuck Labs, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:99%">(Exact name of registrant as specified in its charter) </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.198%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.352%"><tr><td style="width:1.0%"></td><td style="width:34.362%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6YzhhMjNjZmExMDBmNDNkNWJkM2Y0MjQ3NjgyZWJmODcvdGFibGVyYW5nZTpjOGEyM2NmYTEwMGY0M2Q1YmQzZjQyNDc2ODJlYmY4N18wLTAtMS0xLTA_984db547-fecd-4ccb-b3cc-99122f7e33ab">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:73%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6YzhhMjNjZmExMDBmNDNkNWJkM2Y0MjQ3NjgyZWJmODcvdGFibGVyYW5nZTpjOGEyM2NmYTEwMGY0M2Q1YmQzZjQyNDc2ODJlYmY4N18wLTEtMS0xLTA_b779ccf8-ed9d-44ec-983d-1e995ec1a110">001-39593</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6YzhhMjNjZmExMDBmNDNkNWJkM2Y0MjQ3NjgyZWJmODcvdGFibGVyYW5nZTpjOGEyM2NmYTEwMGY0M2Q1YmQzZjQyNDc2ODJlYmY4N18wLTItMS0xLTA_5e97d369-9385-4ac5-8ad7-b1a148e6a9e2">81-2575858</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(I.R.S. Employer<br/>Identification Number)</span></td></tr></table></div><div style="padding-left:49.5pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81Njk_daa6f767-8c81-46d4-bf3e-732c5644b42b">500 W. 5th Street</ix:nonNumeric>, <ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81Nzc_b5d49500-eb1a-4dfe-a45d-0ba286d75814">Suite 1200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81NzE_e763a4e5-f404-453b-b2ea-de9c69b079e3">Austin</ix:nonNumeric>, <ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81Nzg_adb84946-298a-4e79-813b-ea297077fe82">TX</ix:nonNumeric> <ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81NzM_0eb7512b-cf69-440d-934a-ecfcb1fcc99b">78701</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.865%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 25.75pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:99%">(Address of principal executive offices including zip code)</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:99%">(<ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV8zNjg_4322afb5-d915-4a54-aed6-b424c64ab6b8">512</ix:nonNumeric>) <ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81Nzk_a7629878-8f81-48b8-8800-44e74b932f5e">900-4690</ix:nonNumeric> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.673%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:83%">(Registrant&#8217;s telephone number, including area code)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:85%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.429%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6MTVjOGE4ZGEyZDkwNDNhYWE5M2Q1NjI1ZDk1MjVhMTMvdGFibGVyYW5nZToxNWM4YThkYTJkOTA0M2FhYTkzZDU2MjVkOTUyNWExM18xLTAtMS0xLTA_6fdbe148-5734-4712-8cd6-6bea935e6ade">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6MTVjOGE4ZGEyZDkwNDNhYWE5M2Q1NjI1ZDk1MjVhMTMvdGFibGVyYW5nZToxNWM4YThkYTJkOTA0M2FhYTkzZDU2MjVkOTUyNWExM18yLTAtMS0xLTA_2fc35bb6-c267-441c-ae42-fae0f692704d">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6MTVjOGE4ZGEyZDkwNDNhYWE5M2Q1NjI1ZDk1MjVhMTMvdGFibGVyYW5nZToxNWM4YThkYTJkOTA0M2FhYTkzZDU2MjVkOTUyNWExM18zLTAtMS0xLTA_4089e080-282f-4422-8af9-8b68798ec22f">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6MTVjOGE4ZGEyZDkwNDNhYWE5M2Q1NjI1ZDk1MjVhMTMvdGFibGVyYW5nZToxNWM4YThkYTJkOTA0M2FhYTkzZDU2MjVkOTUyNWExM180LTAtMS0xLTA_84092d9a-955a-4929-9dd1-7a195e622da5">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Securities registered pursuance to Section 12(b) of the Act:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.720%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.946%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:85%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:85%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:85%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6N2Y5NTg2NmYwMDcxNGY0Y2I4ZWQ4NzE2NTlhMGRhZjIvdGFibGVyYW5nZTo3Zjk1ODY2ZjAwNzE0ZjRjYjhlZDg3MTY1OWEwZGFmMl8xLTAtMS0xLTA_4d65a43f-5eec-40f6-816a-36941f63116a">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6N2Y5NTg2NmYwMDcxNGY0Y2I4ZWQ4NzE2NTlhMGRhZjIvdGFibGVyYW5nZTo3Zjk1ODY2ZjAwNzE0ZjRjYjhlZDg3MTY1OWEwZGFmMl8xLTEtMS0xLTA_af2e8e43-cc51-47cc-83d2-e9d537b0ad80">STTK</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:85%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6N2Y5NTg2NmYwMDcxNGY0Y2I4ZWQ4NzE2NTlhMGRhZjIvdGFibGVyYW5nZTo3Zjk1ODY2ZjAwNzE0ZjRjYjhlZDg3MTY1OWEwZGFmMl8xLTItMS0xLTA_40d458a4-6e60-4842-b2c6-d165b168adeb">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:94.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6MjE3MzU4ZTY5ZmVlNGU5Yzk3NzAwNGZjNzEzNjFkNGQvdGFibGVyYW5nZToyMTczNThlNjlmZWU0ZTljOTc3MDA0ZmM3MTM2MWQ0ZF8xLTEtMS0xLTA_1f6810d8-b35b-40ac-ae12-e9b77302d5da">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:99%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:99%"><ix:nonNumeric contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6MjE3MzU4ZTY5ZmVlNGU5Yzk3NzAwNGZjNzEzNjFkNGQvdGFibGVyYW5nZToyMTczNThlNjlmZWU0ZTljOTc3MDA0ZmM3MTM2MWQ0ZF8yLTEtMS0xLTA_3f3bb722-04d5-4d3d-890c-a17582b912ac">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i5212526f9d574edfaa944f3d905e2ff1_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02 Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 11, 2021, Shattuck Labs, Inc. issued a press release announcing its financial results for the quarter ended June 30, 2021. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-top:3pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">As provided in General Instruction B.2 of Form 8-K, the information in this Item 2.02 and Exhibit 99.1 incorporated herein shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section, nor shall such information or Exhibit 99.1 be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i5212526f9d574edfaa944f3d905e2ff1_10"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.156%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sttk_2q2021earningsrelease.htm">Press release issued by Shattuck Labs, Inc. regarding its financial results for the quarter ended June 30, 2021, dated August </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sttk_2q2021earningsrelease.htm">11</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sttk_2q2021earningsrelease.htm">, 2021.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from the Company&#8217;s Current Report on Form 8-K formatted in Inline XBRL.</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i5212526f9d574edfaa944f3d905e2ff1_13"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.380%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shattuck Labs, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: August 11, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dr. Taylor Schreiber</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr.&#160;Taylor Schreiber</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(principal executive officer)</span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>sttk_2q2021earningsrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i255dfbb30d194b068c5654e90cf4cdcc_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:64px;margin-bottom:5pt;vertical-align:text-bottom;width:256px"></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">Shattuck Labs Reports Second Quarter 2021 Financial Results and Upcoming Phase 1 Dose Escalation Data for SL-172154 and SL-279252</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:122%">&#8211; Announced submission of abstracts for the initial Phase 1 dose-escalation data from both SL-172154 in ovarian cancer and SL-279252 in advanced solid tumors for presentation at the Society for Immunotherapy of Cancer (SITC) Annual Meeting in November 2021 &#8211;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:122%">  </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:122%">&#8211; Reported initial safety data from SL-172154 (SIRP&#945;-Fc-CD40L) Phase 1 trial in ovarian cancer suggesting an encouraging early safety profile and ability to dose escalate beyond prior CD40 agonist antibodies &#8211;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:122%">&#8211; Announced plans to study SL-172154 in hematologic malignancies, Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS), with an IND filing anticipated in the fourth quarter of 2021 &#8211;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:122%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:122%">&#8211; Reported plans to continue dose escalating in the SL-279252 (PD1-Fc-OX40L) Phase 1 trial in advanced solid tumors based on trends in immune response data &#8211;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">AUSTIN, TX and DURHAM, NC, August 11, 2021 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">-- Shattuck Labs, Inc. (Shattuck) (NASDAQ&#58; STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today reported financial results for the second quarter ended June 30, 2021 and provided recent business highlights. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">&#8220;Over the past quarter we have begun to compare and contrast the immunological effects of CD40 and OX40 stimulation in cancer patients treated with SL-172154 and SL-279252. We believe the emerging data validate the hypothesis that the ARC platform can uniquely activate the TNF superfamily and indicate that the effects of OX40 stimulation are far more subtle than innate immune stimulation of CD40. We are excited to share this data in just a few months' time at the SITC Annual Meeting,&#8221; said Taylor Schreiber, M.D., Ph.D., Chief Executive Officer of Shattuck. &#8220;Discharging the perceived safety risks associated with dose-escalating a CD40 agonist has enabled us to broaden our clinical development strategy, including an expected IND application for expansion into both Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndrome in the fourth quarter of this year.&#8221; </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">Second Quarter 2021 Recent Business Highlights and Other Recent Developments</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:122%">ARC Clinical-Stage Pipeline</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:13.8pt">Continued Enrollment of SL-172154 Phase 1 Clinical Trial in Ovarian Cancer with Encouraging Safety Profile&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">The phase 1 trial is an open label, multi-center, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, anti-tumor activity, and pharmacodynamic effects of SL-172154 administered intravenously in patients with platinum resistant ovarian cancer.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:122%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">SL-172154 is a dual CD47&#47;SIRP&#945; inhibitor and CD40 agonist. Today, Shattuck reported continued enrollment at the fourth dose level, 3.0 mg&#47;kg, and plans to advance to the next dose level, 10.0 mg&#47;kg. To date, no evidence of anemia, thrombocytopenia, cytokine release syndrome or liver dysfunction, nor other dose-limiting toxicities have been observed. Prior CD40 agonist antibodies have encountered dose limiting toxicities at doses of greater </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">than 0.3 mg&#47;kg. Initial dose-escalation data from the trial have been submitted for presentation at the SITC Annual Meeting, to be held in November 2021.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:13.8pt">Anticipated IND Application for SL-172154 in AML and HR-MDS&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Shattuck plans to submit to the U.S. Food and Drug Administration an investigational new drug application for a phase 1A&#47;B clinical trial for SL-172154 in patients with AML and HR-MDS, anticipated in the fourth quarter of 2021. The trial will evaluate the safety, tolerability, pharmacokinetics, anti-tumor activity, and pharmacodynamic effects of SL-172154, as both monotherapy and in combination. In AML, Shattuck plans to evaluate SL-172154 in combination with both azacitidine and venetoclax. In both HR-MDS and TP53 mutant AML, Shattuck plans to evaluate SL-172154 in combination with azacitidine.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:122%">   </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:13.8pt">Continued Enrollment of SL-172154 Phase 1 Clinical Trial in Squamous Cell Carcinoma of the Head and Neck or Skin&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Shattuck continues to enroll patients in a Phase 1 clinical trial for SL-172154, administered intratumorally, in patients with squamous cell carcinoma of the head and neck or skin. The Phase 1 trial will evaluate the safety, tolerability, pharmacokinetics, anti-tumor activity, and pharmacodynamic effects of SL-172154 as monotherapy. Initial dose-escalation data from the trial are expected in the first half of 2022.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:13.8pt">Additional Dose Escalation Cohorts Added to the SL-279252 Phase 1 Clinical Trial&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">An analysis of data collected across a dose range of 0.0001 through 6.0 mg&#47;kg, on two dosing schedules, demonstrated dose dependent OX40 receptor engagement of OX40 expressing T cells, and a primary pharmacodynamic effect showing rapid egress of these target cells from circulation. This effect has not been reported for prior OX40 agonist antibodies. No dose-limiting toxicities have been observed to date. Based on these data Shattuck plans to enroll additional patients at dose levels of 12.0 and 24.0 mg&#47;kg. Because very few of the patients treated to date are known to express PD-L1 within the tumor, Shattuck plans to enroll patients with known PD-L1 positive tumors in the additional dose level cohorts. The Phase 1 trial is an open label, multi-center, dose escalation, and dose-expansion study to evaluate the safety, tolerability, pharmacokinetics, anti-tumor activity, and pharmacodynamic effects of SL-279252 as monotherapy in patients with advanced solid tumors. SL-279252 is currently being developed in collaboration with Takeda Pharmaceuticals. An abstract containing data from the dose-escalation cohorts through 6.0 mg&#47;kg has been submitted to the SITC Annual Meeting, to be held in November 2021.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:122%">Corporate</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:13.8pt">Appointed Chief Technical Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">&#58; In June 2021, Abhinav A. Shukla was appointed Chief Technical Officer. Prior to joining Shattuck, Dr. Shukla was the Chief Technical Operations Officer at Redpin Therapeutics and was responsible for all aspects of process, analytical and formulation development, and cGMP manufacturing. Previously he held several senior leadership positions, including Vice President of Manufacturing at CRISPR Therapeutics, Vice President and Head of Biologics Process Development at Shire, and Senior Vice President of Process Development and Manufacturing at KBI Biopharma. Shukla received his doctorate in Chemical and Biochemical Engineering from Rensselaer Polytechnic Institute and his undergraduate degree from the Indian Institute of Technology, Delhi.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">Second Quarter 2021 Financial Results</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:13.8pt">Cash Position&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">As of June 30, 2021, cash and cash equivalents and short-term investments were $304.8 million, as compared to $335.4 million as of December 31, 2020. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:13.8pt">Collaboration Revenue&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Revenue for the second quarter ended June 30, 2021 was $(4.2) million, as compared to $3.2 million for the second quarter ended June 30, 2020. The negative revenue was driven by increased expected costs required to complete the performance obligation contained in the Collaboration Agreement with Takeda as a result of changes to the SL-279252 clinical development plan.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:13.8pt">Research and Development (R&#38;D) Expenses&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">R&#38;D expenses for the second quarter ended June 30, 2021 were $14.9 million, as compared to $7.8 million for the second quarter ended June 30, 2020. The increase was primarily driven by increases in clinical development, manufacturing, personnel-related costs, and laboratory capabilities.</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:13.8pt">General and Administrative (G&#38;A) Expenses&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">G&#38;A expenses for the second quarter ended June 30, 2021, were $5.4 million, as compared to $1.7 million for the second quarter ended June 30, 2020. The increase was primarily driven by an increase in personnel related costs to support the operational expansion and costs associated with being a public company. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:122%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%;padding-left:13.8pt">Net Loss&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Net loss was $23.6 million for the second quarter ended June 30, 2021, or $0.56 per basic and diluted share, as compared to a net loss of $6.2 million for the second quarter ended June 30, 2020, or $0.81 per basic and diluted share. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">2021 Financial Guidance</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Shattuck believes its cash and cash equivalents and short-term investments will be sufficient to fund its operations through 2024, which is beyond results from its Phase 1 clinical trials of SL-172154 and SL-279252. This cash runway guidance is based on the Company&#8217;s current operational plans and excludes any additional funding that may be received or business development or additional clinical development activities that may be undertaken.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">About SL-172154</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">SL-172154 is an investigational bi-functional fusion protein designed to block the CD47 immune checkpoint and simultaneously agonize the CD40 pathway. SL-172154 is currently being evaluated in Phase 1 clinical trials for the treatment of patients with ovarian and head and neck or skin squamous cell carcinoma.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">In preclinical studies, SL-172154, demonstrated evidence of bridging the innate and adaptive immunity, antigen cross-priming to CD8+ T cells, and durable receptor occupancy, leading to superior anti-tumor activity over anti-CD47 antibodies, and anti-CD40 antibodies, both alone or in combination. Additionally, SL-172154 preclinically demonstrated a favorable safety profile with no evidence of hematologic toxicities observed with other CD47 inhibitors. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">About SL-279252</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">SL-279252 is an investigational bi-functional fusion protein designed to block the PD-1 immune checkpoint and simultaneously agonize the OX40 pathway. SL-279252 is currently being evaluated in a Phase 1 clinical trial for the treatment of patients with advanced solid tumors and lymphoma. SL-279252 is part of a collaboration with Takeda Pharmaceuticals. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">In preclinical studies, SL-279252, demonstrated evidence of high monotherapy activity, potent stimulation of OX40+ T Cells and superior anti-tumor activity over Anti-PD1&#47;L-1 antibodies and Anti-OX40 antibodies, both alone or in combination. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">About Shattuck Labs, Inc.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Shattuck is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Compounds derived from Shattuck&#8217;s proprietary Agonist Redirected Checkpoint, ARC&#174;, platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. The company&#8217;s lead wholly owned program, SL-172154 (SIRP&#945;-Fc-CD40L), which is designed to block the CD47 immune checkpoint and simultaneously agonize the CD40 pathway, is being evaluated in a Phase 1 trial. A second compound, SL-279252 (PD1-Fc-OX40L), is being evaluated in a Phase 1 trial in collaboration with Takeda Pharmaceuticals. Additionally, the company is advancing a proprietary Gamma Delta T Cell Engager, GADLEN&#8482;, platform, which is designed to bridge gamma delta T cells to tumor antigens for the treatment of patients with cancer. Shattuck has offices in both Austin, Texas and Durham, North Carolina. For more information, please visit&#58; www.ShattuckLabs.com.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">Forward-Looking Statements</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:121%">Certain statements in this press release may constitute &#8220;forward-looking statements&#8221; within the meaning of the federal securities laws, including, but not limited to, our expectations regarding plans for our preclinical studies, clinical trials and research and development programs, the initiation of any dose-expansion cohorts, the anticipated timing of the results from those studies and trials, the anticipated timing for IND filings, anticipated timing for preclinical development updates, the potential for our proprietary ARC technology and GADLEN platform, the clinical benefit of TIGIT blocking antibodies and T cell engagers, additional uses for our proprietary ARC technology and GADLEN platform, potential new uses for our product candidates, and expectations regarding the time period over which our capital resources will be sufficient to fund our anticipated operations. Words such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;objective,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;design,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;develop,&#8221; &#8220;plan&#8221; or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While we believe these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in our filings with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;)), many of which are beyond our control and subject to change. Actual results could be materially different. Risks and uncertainties include&#58; the recent and ongoing COVID-19 pandemic and associated public health guidance measures&#59; expectations regarding the initiation, progress, and expected results of our preclinical studies, clinical trials and research and development programs&#59; expectations regarding the timing, completion and outcome of our Phase 1 clinical trials&#59; the unpredictable relationship between preclinical study results and clinical study results&#59; the timing or likelihood of regulatory filings and approvals&#59; liquidity and capital resources&#59; and other risks and uncertainties identified in our Annual Report on Form 10-K for the year ended December 31, 2020 and subsequent periodic and current reports filed with the SEC. We claim the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We expressly disclaim any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">The Company intends to use the investor relations portion of its website as a means of disclosing material non-public information and for complying with disclosure obligations under Regulation FD.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">Investor Contact&#58; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Conor Richardson</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Senior Director, Finance &#38; Investor Relations</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Shattuck Labs, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">InvestorRelations&#64;shattucklabs.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:122%">Media Contact&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Stephanie Ascher</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Managing Director</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:122%">Stern Investor Relations, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stephanie.Ascher&#64;sternir.com</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i255dfbb30d194b068c5654e90cf4cdcc_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">PART I - FINANCIAL INFORMATION</font></div><div style="margin-bottom:0.08pt;margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Item 1. Financial Statements</font></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">SHATTUCK LABS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">BALANCE SHEETS</font></div><div style="margin-bottom:0.08pt;margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(In thousands)</font></div><div style="margin-bottom:0.08pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.241%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">June 30, 2021</font></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">December 31,<br>2020</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">(unaudited)</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Assets</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">86,494&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">157,898&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Short-term investments</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">218,304&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">177,551&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">11,080&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,190&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">315,878&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">345,639&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Property and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,571&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">331&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">349&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total assets</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">323,780&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">348,988&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Liabilities and Stockholders&#8217; Equity</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accounts payable</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,007&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,754&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accrued expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">11,326&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,352&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Deferred revenue</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,778&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,728&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15,111&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">16,834&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Deferred revenue, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">29,215&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">21,306&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Deferred rent</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2,367&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">987&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">46,693&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">39,127&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stockholders&#8217; equity&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Common stock</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Additional paid-in capital</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">386,206&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">382,012&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accumulated other comprehensive loss</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,620)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(63)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Accumulated deficit</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(107,504)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(72,093)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total stockholders&#8217; equity</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">277,087&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">309,861&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 41.5pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities and stockholders&#8217; equity</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">323,780&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">348,988&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i255dfbb30d194b068c5654e90cf4cdcc_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHATTUCK LABS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(Unaudited) </font></div><div style="margin-bottom:0.08pt;margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">(In thousands, except share and per share amounts) </font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.182%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Three Months Ended June 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">Six Months Ended June 30,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2021</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">2020</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Collaboration revenue - related party</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(4,231)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,181&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,961)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">6,157&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">14,882&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,755&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">25,219&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15,892&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">General and administrative</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">5,399&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,746&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9,755&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3,346&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Expense from operations</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">20,281&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9,501&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">34,974&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">19,238&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Loss from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(24,512)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(6,320)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(36,935)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(13,081)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other income (expense)&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Interest income</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,000&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">138&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,696&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">387&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Other</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(86)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(26)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(172)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(68)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total other income</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">914&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">112&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,524&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">319&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net loss</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(23,598)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(6,208)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(35,411)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(12,762)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Unrealized loss on short-term investments</font></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(960)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(97)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1,557)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(36)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Comprehensive loss</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(24,558)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(6,305)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(36,968)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(12,798)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Net loss per share &#8211; basic and diluted</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.56)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.81)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(0.85)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(1.67)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Weighted-average shares outstanding &#8211; basic and diluted</font></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">41,906,268&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,646,149&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">41,840,555&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">7,633,565&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>sttk-20210811.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f578a81e-7792-4eab-9554-4c47e1dcf5d1,g:2d6d3d14-999c-41d9-b62c-116f2fa9b40b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sttk="http://www.shattucklabs.com/20210811" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.shattucklabs.com/20210811">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sttk-20210811_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sttk-20210811_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.shattucklabs.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>sttk-20210811_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f578a81e-7792-4eab-9554-4c47e1dcf5d1,g:2d6d3d14-999c-41d9-b62c-116f2fa9b40b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_PreCommencementTenderOffer_3e62cd42-57d0-4ac6-9c71-4143a3ef19f8_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_66d45836-efb2-47ed-9d9d-8db788c93c51_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8520ccb6-e49f-4a4c-aacb-3a314b86149f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_fe403441-7965-495f-bed0-65c864c10525_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_bad58364-d831-4a58-9a26-2aa60f50a6cf_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_dcfde209-5e0c-4386-a271-8021f18f0666_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_e05db5b1-9efc-4111-9242-c31ecf43391b_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_a1810fcf-8d99-4f74-bdb9-351fb0a48320_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_367d420e-600e-4587-a803-3b0d721f9b81_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_e0438fbb-e5cc-4440-a218-a99531f33ac4_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_894c7256-a4a8-46e0-9415-fb4e9ba0c38c_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0e1fcb96-7658-4d0e-9d47-63a1009d5cf8_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_bb70d613-8955-4181-96c4-2ec8eebd92c2_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3a2ed5eb-982a-450c-a62d-797b9aa72a2a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7c432814-8934-4d96-9e2e-8fa24bd102bc_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8e3789f2-3d5b-4544-9b6a-263edcfb04bc_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1f56af2c-32da-44d1-8549-ce6024269d83_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6d34e650-f941-4e1c-a01d-7bc3128042df_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_118c0b6b-bc9a-4699-a772-14c922f24205_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b2aa0dcd-7a6b-4392-b699-36bde16e4519_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ab4606e6-9cc9-4c3a-909c-2a32e941950f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_8e2b8009-3646-4c78-b545-edf62b0bc45c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2047bb4a-94fd-4e85-a6fc-35f887436ee7_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f4baa402-9c5b-41e4-81d9-5921ce9f544a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>sttk-20210811_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:f578a81e-7792-4eab-9554-4c47e1dcf5d1,g:2d6d3d14-999c-41d9-b62c-116f2fa9b40b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.shattucklabs.com/role/Cover" xlink:type="simple" xlink:href="sttk-20210811.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.shattucklabs.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_eea4c585-d486-43d7-8eb8-538cae5ec41a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_DocumentType_eea4c585-d486-43d7-8eb8-538cae5ec41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5493d6c1-f289-4883-8795-bb9212c27ae6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_DocumentPeriodEndDate_5493d6c1-f289-4883-8795-bb9212c27ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_737cce7c-72d2-4b94-a09f-f727f18c1347" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_EntityRegistrantName_737cce7c-72d2-4b94-a09f-f727f18c1347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_747136a0-2e1f-4630-92a2-7bb515a15a2f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_EntityIncorporationStateCountryCode_747136a0-2e1f-4630-92a2-7bb515a15a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d659096c-b876-4437-a2a8-32b28a33b5b2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_EntityFileNumber_d659096c-b876-4437-a2a8-32b28a33b5b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f457a2a9-86a2-4778-9ad0-528ceefd1b89" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_EntityTaxIdentificationNumber_f457a2a9-86a2-4778-9ad0-528ceefd1b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2c9c22f4-d47c-4da4-a399-d42d7954b58a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_EntityAddressAddressLine1_2c9c22f4-d47c-4da4-a399-d42d7954b58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_71a35f85-611f-4bc1-a069-7dd3040b8961" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_EntityAddressAddressLine2_71a35f85-611f-4bc1-a069-7dd3040b8961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b366e77d-4a94-4096-a5d7-7ca4e15ed8f1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_EntityAddressCityOrTown_b366e77d-4a94-4096-a5d7-7ca4e15ed8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_881066e9-46e6-4c73-bee3-6f69422a0829" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_EntityAddressStateOrProvince_881066e9-46e6-4c73-bee3-6f69422a0829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1e3785dd-d508-45da-bd70-7c29d1bdc6d3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_EntityAddressPostalZipCode_1e3785dd-d508-45da-bd70-7c29d1bdc6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_7db863ad-60c5-4fa3-99e3-ea3adf43138c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_CityAreaCode_7db863ad-60c5-4fa3-99e3-ea3adf43138c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ae92e679-755d-433c-acb5-f798e73eb750" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_LocalPhoneNumber_ae92e679-755d-433c-acb5-f798e73eb750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_b631f62f-e916-40e3-90b9-4c5560b85f99" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_WrittenCommunications_b631f62f-e916-40e3-90b9-4c5560b85f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_411aaaa8-51ad-4ec5-b298-036b5746461c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_SolicitingMaterial_411aaaa8-51ad-4ec5-b298-036b5746461c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_6aa91573-21a7-4794-acae-536261a09cf1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_PreCommencementTenderOffer_6aa91573-21a7-4794-acae-536261a09cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_a0db6ff6-af10-4f0c-9821-fd5287e686fd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_a0db6ff6-af10-4f0c-9821-fd5287e686fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_5389d590-0979-4276-9c59-b105e4bc8954" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_Security12bTitle_5389d590-0979-4276-9c59-b105e4bc8954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2f94ba11-83ea-43f5-b0f2-106bea347e02" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_TradingSymbol_2f94ba11-83ea-43f5-b0f2-106bea347e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4c2c2968-20c0-441d-9ec2-14620e4a5665" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_SecurityExchangeName_4c2c2968-20c0-441d-9ec2-14620e4a5665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c44e1cfb-8678-422f-b0b8-d6b8dd372e6b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_EntityEmergingGrowthCompany_c44e1cfb-8678-422f-b0b8-d6b8dd372e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_426dd61c-cce1-4a45-8116-fbceb9b86561" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_EntityExTransitionPeriod_426dd61c-cce1-4a45-8116-fbceb9b86561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_3f77835d-b0f4-427b-ba01-ca162ef4d345" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_EntityCentralIndexKey_3f77835d-b0f4-427b-ba01-ca162ef4d345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1eb90cda-8873-469b-bc9b-a00a43ab47be" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2a082a10-79ad-4f6e-9c12-34b57534e751" xlink:to="loc_dei_AmendmentFlag_1eb90cda-8873-469b-bc9b-a00a43ab47be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_2a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_2a.jpg
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M 1   1 01@ !4A@G2($ "(  "!0P @B0!6S T5T0  $0  %A!! @A7&"% B
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M@$Q.3&#SR<Y6I)AJ5!3GT#R\=U^&(8-*$  !$  !)0BH)T Z.SNS@6DTBM1
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MVSP>GSD;>^-F0GRBBXMK97]_]WIUK+WY0B>LB(N-HVT>_<<-T[SD;6USR(,
M"(  "$A(P.$"I&U]NQKZ<>XF0OV&1?H80BRIRLG6Z)Q< @8M,Z?V]#?3$^+T
MV;/\^R#?[=1-6\=LM(X,W_/7L>.Y&HS57/6F/4N4> <G7MDVHF@% B   O8F
MH(8 >7[3X&S]I>4,D+FU5;6-AG]N#O7ORR=D9F3R!$B_RE7]>PTQUWSO)S/3
MTS*89]'QA0"I_R'#=%OX&6/%4JZ][PC8!P$0  $0R"60[P/DE6T?I20G4D=X
M J1AQ;71L.7F!OV/U5-3DI*>5_#18\D->!IJ]DKC9CYOM377,&QJL&'":CY
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ML:VLRCD]Y+1(DB-'CGPWT,9<Z/8=.HC_;A7(<\+X\6^\\<+#J[D>"51HE9C
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MR@!)I5,]&YPHY%Z4JKLY.;L5\RKKV4#N5)'*3D[.0C!IM!I=[??X):]M_^+
MPO&_SOOXUWGC?U\ZS:+:VJ^\8E'&(%#,RTN@I&UB0[=-]"E3RL65L#L7*5[T
MHW![+J[:U@4AK3P]/;MW[TZ/C;1V1UNR6C1O+J256F7"P\--ND:A\=DS4^O6
M)K^B1![*/U0K"O1+900N7+A :\4)B50!QO2BE8EUZ];1OB!ENBQM@"2?70J]
M=*!XP+'B 4=<:FY7H _^O;X28J7Q\)4\8M$'OCNT:%SDC6LYSS=+I*:F[)LS
MX>ARVKSXPHNTO$JJ=NTAQ#3)M)X^1J"DS6+=5@T<LO7C8=O']]_XH<U*'+SA
MQ@T;>EO*27'P+DCE'FT%,U'E7Z=.X<*%#3\<-I1CV6;OWKU268<>$)"/P((%
M"T*F3N74[^WMO3LLS+MD2?FLFVB6/$ JYOE_ANKU6\?_PJ/QAWQ[$"]NFG?Y
M[!G.(B_)20D_SPIA;ETRUZOVL^86>OZM9$X&=>;L<$^HVF1B4A)[*]C<N2\4
MP1@ZA*-Z\!2I\U94C1F=,R5 2SBS9\VR.4-'"-"1HT;]?O0HIR3EXZQ;NU:(
M$@EEU! @"4?=OFM>ZSW")$Q2VFK#M]LU&KZ:A]>5_RUZ9&GA_J=-&R@YU)R2
MP"DA :^_4"7+*.E;OERW)3(6T)'P/H"J?$2 WLV8>-N@00.3G[1MRU% ^.)%
MZS;OYB,F<%4F E2RCB*BX4-+."^__+),AD@M5?_@S"9S=755(!^'LU]2;O.0
M!-S#(T,2XI]2;?%*[WUOH\+8LQF/'SI7LUQA*_%4V)FCAX2<!ZEAM*VFS>/W
MYVI8>$Y*:EI:NE;G5-C%I5*W#M;Z?V3!YMO7;C,:3=^O@ZUMZVCR[$)E5$F5
M+C%^%BM6;,TWWXC18&S+F;)/N4[L]!9KS=%&9G8&+RF1ZKG[Z-&C\Y^_:S3Z
MQJE\RY8MWV_98N(_%;/]?"7?ZP9K^VN09_,47PY0H"?KUZ]GES/MVJ5+7XFJ
M<?+?,R*'5=IM'I%W[HP889H,V+A1HRE3I@B$*;>8N6T> S_XX.'#AYS6J4CO
MY$ET-K!]+L>:0=X([QP?]YB^8C(S,JZ%=GMZPJ9Q]:HG)#H2[_,GN>?R[*'0
M+\"F6Z@I6KU]VQH]NKS<KY=_[VXV1,?-P^?<NAJA_W;-R/QVP&?A4TU3@NUS
M@]AJE?;>F33-S,Q,%7=1DAY]$=.']F;9ZA=?.PILE% N\N*,CA)ZNV#A0A-M
MYO;/].S9DQZ]383I"?V?RY<E] >J0$ D@0X=.YJ+CCNV;[=C=*1^.5" O/MK
M#Y-J<#'W(ACFB$CZ/,TS,\TFX+!;'?V2;ZE6I).[)JV@^)%72<S=Z,@?_Q*I
MUH[-S;UFE\0EVKFL9#%K27R61,F&C1M-7I:[N[N'F)\?L!=CR8W9LV=+X@R4
M@( D!#B?*;V\O&AV[F+779@.%2"?I*>ELG%?"_U:DC'@4F)=V;DD&4ZE,'H5
M%_N4[>&)_4(GN+(ALEUQD<*%/3P\;&\OH"7M(!8@I2H1*JEETA_:]\+3PTX=
M.Q8O7MQ$@*J1;=RT255<T!G5$8C-O>S>+8>9029Q9XK2DJ-<C)*L*Z6=)9\G
M+TP=_^MN6JKIP6ERH9!'+Z5KRZ/XF5:J026K?D=3/NW%2GOD'KV4I1#([^>X
ML1P'D>Y2I B<HP&$/_F+0+_^_>?-LY#Y(7>/'"9 %N8^YE<GK Z +9@*5[*J
M%;M:C57-^83-9*ZXNIF^0)+,HB**ROGYT2()K0&*SWQ1Q%^&AIB6=$1>(A.1
MS/7TVO7KY\Z=,_FMR=8.SK;UZM4S[H\T"M![5IG>XRHS4K"B)@(\ZZC'CA^W
M[\L4!\IBO1'>@0IMYY8[)Z_H'_K_5N]$6QCEVA9Z9.D8VKXA)(N5G'%V*_3.
MQ)DRW9?[/EUS_\X]<N99J7']MA)-XS9OU^IJ>W5OF5RUHUJJ+1<3$Y/7 9MS
M".4H/&UT3 [E;)VE2I42GM,KATMY!P)9K+;]72"+E;@9_HKY V%@8. H5G$,
MVYA;U<IA9I ,4[GMKKP;&6GC8?4Z=(*)7-&1,#E;\P98ONA(G@1.'V2RB;-!
M\Z:(CB:WLMW?V%OUIR6A\,6__V9K,^;T&C)[^3^<S@SA*K@CH=M0I0("'WSP
MP;+ERY.3DQ.Y"K])V$$*DWY^?N84[MNW;X(]-GLX4( D-)7;[JP2-*=J8,]J
M'4*J=]S*U!@GX0"P535IR;&9FM.BP/75L"G3=TR<NF/BM,P+5F?2]_UZ6I]I
MH]IT[SA@TJ@!WT[S[UN@"XW*.N[Y3KE,^]CNTR7GH=;YCC,<YB1PX,"![CUZ
M].S5R_ 0]K%L=5"_6+V:,^_:X-65RY>57VYUK "9RZ$&4Z@SU<:Q]F9]>F+E
MZ76#3Z\=<GK-T#^_&7;JZ^'TN;:=MY!-]3?\*EA^$TESN\ 0.G/1['5J]1>[
M@D-")X<8\I4I$7_7ILW;/IZV;9SEBN=YE6HK>/H$^C,UBUO;=\BKF,":-3+N
MB!UICV4K%0]60>C:U:M7Y>MFSQX]0G?NY,E:H!C91^H2$#S=<<  :0O\\]\-
MB;A\@=TR]E'TB2^H>+?9_8Y5.H^VF%71I&4K'I_VS)QQ+RK*G,"V\3-LZ8]:
MVL0^>3)VW+C18\:HI4-VZ$=8[AL:F:[T]/0UZ];)I!QJ0< & O2%3,?UT#Y(
M<VV?/GU*,UH;--O01 T!\NR&@51_AJ?S?ZSF^X)N-F9A\_X<E9U)H8N+6ZNI
M"XHV-+O:&38UF(K^\)BFXT&VCR]PV_56KEQI6(WIUZ_?]>O7;]Z\:<.MB29$
M8-[\^7)S^&G/'KE-0#\(6$M@P_KUP<%F*V[2.U'Z>OGQQQ^M56NMO Q9K/<'
M/+Y-.05.)1K1%I8WK77(6OFK.T8G)28PC"8[F])?:7WS6?JK/@^6_B^;.JA/
M#64TNL;#5UA6?OG8N9-_>)<N6[95!X:ATY[YKJB]X6>.'S-DV^8FH!H^>HL&
MT_H?,OK_I?,@6TWC"]*6';,D\6#OK6U?Z0MO5O>O&3C;PMXX2\K$_M[D50&M
M4=,A-6*5,LSP#S^,>G&RKOHL5O9+E]JU:[_YIHU_5JDI*50B@%VXA)(CZ/6/
MF %"%JMM]#BS6#MTZ/#!P($V*)2C%BLEZ<2PJJ3:_'=GKA8K3V>I$!U/^49G
M9^>=.W;8P$I@$VEGD*E/3KT:&ZG/N*.B<0^/3WYXC/N8"X'."1"[1B=2"1"C
M<)6=>GZ79<E:3>OV'U^V54^+T9%4_4714=CU]+&\)2&^ZKI@VS?/RE+_>_'?
M%6WMO+O6A KG46+"R+T@E9:6ORLG6-OEP8,'FS2A3:7SY\UKT[JU;9].G3IU
MZ]:-[8;)8X>U?D+>9@*/'CUBMW72Z6Q36+Y<.7;#^ 1!WY#F+-*66=N<D:K5
MKM!0.NN4QSUZ.(NX=4LJ<R9ZI)Q!/OFS;NXN1EWN1(K^H:59E,_K@QC&EJ<A
M(1V./C S^FYD[HS-P@R2)G8ZG7/#84N%J!4HLWMJL-ZR@!DD>>A5TCMPZBB!
MFJT2V]Q_55Q\O/ZDYVQ].\-.2C>W0D.VC[9*CX3"BB6;V?PD*^N^0$F4__S+
M+ZM6F9YCNF3)DFI5JXH<*7.C8S-,\J? SB!%C@5G<RK/34=8V*99F3\]FV\5
M&V:0!@Z'#A^FFY^'2<F2);^5X6VZM#-(#O\?':/#%.6Z'MR+%*[:JM+DEM5>
M,7N*,F?;^"=/+.NT22(N/H[=CA;3;%(F3:. ^O6E452 M;"C(ZU4BX^.1'39
M4N['1&SYX+_=%"L(97-T)/]IR5'N/QI/\^DS\IEN_M9;%)5YMMO17)P68R5W
M0/8 F4W3&35>L3$/K.I65I8Z.7!"F#'-NOTM5I$T"C=IHMHR0S^&A[.9;-^V
MS390)JVJ5*EB4I7"(# 6R<:\?&GV(PE_?B6>GIYBK- K:C'-A;3MV*&#$#$Y
M9&BY-2 @P)QF>E5)$VCVX:!B/)$]0'H4*2'&/X=MZ^5;QBK?%'O\M,HK^83E
M?I*EK_C@R9/E\]^^FK_^VO00&T.=6*F\6KMV+5M54G+RNF^_E<J$^O3T>?]]
MJ@XO=[^6+U\NQL2LSSX36-7$-BNDW(X!DGR>,7WZ^F^_Y=F;1P=H4Y5SVWK'
M;B5E@"SDSG'WN+\B8XH1YX.P>33ZO%;)KFHUK5+EY2-7S;P/IW$<UU#G-7^K
MW)-<F%++Z,QD.?Y6Z5&#RI!*DA8K>:\E43A[#D=5"GIVED2Y08DWO;$IP?'D
M&BJI%0D==A!5WVW:5+%B19D>=BD#:_'BQ9ZLX\FL[3O=*O0'8N5WHV4CU.OR
MY<M+>Q]:MLHE4:)$"2HFX./M;:XYG9-%4\G34ISV(V62#KD;_U>CS(PL8Y*.
M=Q-*!_W(-@I"6L6=6'SSZB6!23I.3BX-AO*]YA5B,:^,54DZ/9;QUO2QUO:+
M\CL_6G_OSGUCDHZ;F]O@K6/$J92R]>;OOZ>CJ;)>/!':!@-E_?PF3IA@0T-V
MD]&C.3*81#Z\&ZV(5,YN7MK75X[I,J>?%2I6Y#PABQ\[6Q4]&_%G54@RCJ2$
MJG3N86WE# H*:M&BA50F./6L7+4JXOIU2H\7:<6C2)%)DR85+5)$I![.YO,6
M++A_]ZX8S1JMMEJU:B,^I'(K$EP3)DY,9^6BV_QW-V/&#"H:P.-6F;)E)TV<
M*,9OB0/D<U?N, Q'PK$81\VT33JW<93  -FD4Q_&EZJ?F[L2[_ZRZ_*YLP9M
M3CKGYCWZ,.7X%O2C]_U\\K<C0K)8BWIZM9ZN2,1*I^H&,F"&2A   1 H> 1D
M"I#*@7QT9.Z=6]<L;O-P+>3QZ@"S14F.?SZ%TCX-QVP9 J3AY"GZ5\N.W36U
MS+X6WCUM"B4A\1<*T&IU7185Z()SRMT-L 0"(  "TA'(]P&24/SSP\BTU!2>
M2CI:K5.#H6;+Z!Q:I'^'][P(CFF I-,BBQ3S;#K*;-&C?7-F)R<FFZNDH]4Y
M=5Z(Z"C=#0M-(  "(* 4 2F3=)3RV=1.[>Z?\[^1YHF.ORWER' Q,1#_],F_
MV\SNY@R<$N)1M"AGWW5:+:*CO>X*V 4!$  !D034,(,T(KCTO[$I24F&EX+T
M<79QK==_$L/XFF-T(VS5G8AK-$?DGT$:2KRVGFZA;'3BR=,G#QVAXQ%T3BXU
M_.M4".([ T3DL*$Y"(  "(" W 0<+4!&1.R>: AO%:J^XN(_5=;^'UWQ<59F
MEL  V;)+-Z?:K\GHSZ/L#9-G&0K%5:E5_8V)W66T!=4@  (@  *6"#C2$FM.
M6,2/XXT.W[YVX<:/?2SY+^KW/$7BV7I_VR/CT2HI)VYM")YE-!IQ^>J&07-%
M]0V-00 $0  $Q!%PH !Y<X]I%8_,C/2H?</$=9"GM75%[C/2: N%7-?6M1M-
M5%/PWC?3](=RF8=>$  !$  !%@&'"9#IISA')RGAJ5RCEL1QT R/K>QLOC.9
MY7#R872,'&JA$P1   1 0 @!APF09FJ:2UXPZ3\HA2L) 624T3G)7B;?*G\@
M# (@  (@("L!APF0KHTX^UFDN-F">[)R82OW+5=>/HL:+4>=6"]ON<JWRM<1
M: 8!$  !U1!PF #),)5>>=T$J\[)R?=MLQO\Q8^!6Z%"PI6\U&>(<&%K)9NV
M>MNT[SI=Z\_Z6ZL'\B   B   E(1<*  R90;7\+'S]@QJM!6)6BS5/WDU--P
MF-!,4:U.7E!5.C:MV_B_0X9I8;G?&K.U>V1E N4@  (@  (& HZV#U+I<4G[
M:\_Q@_O)*D^I.4:C;14R3VG/8 \$0  $0,"N! IZ@-3#OW[LT*[MY@*DJUOA
M-\?-M.L8P3@(@  (@( =""! /H-^;OV\QS$Q>4_ST.F<&S0/]*C?W [# I,@
M  (@  +V)H  ^>((1%Z(O7N7BJD6JR_O::OV'G?8!P$04"V!)4N?G0P_;NPX
M23JY8N6*S-P#SZU5>/R/XR=.G+#H V5=#!D\I'#APA8E26#MNK5Q<7$\DO[^
M_H$M X6HLBBCM@!Y[]?Y]R-OTBG?WJ7+56P78K'_$@K$'#AT[L2IA+@$%U>W
ME^H'5$2Q<@GA0A4(@(!@ I('2*-"%Q>7D2-&"G:$$1@@#0J+%R\^<,! 'N4/
M8AYLWBPH<Y,B[M@QED]JLM@1507(LQN&9672^<7/3O.@SC<8LIQA7"Q2$"\0
MO>_7/PX>?OXB4Z_/W;U(FT_H+!%<(  "(* H 6D#I''Z:.A#4%!0U2I5!?;'
M&"#+E"D3U"Z(L]4_E__Y[;??#+_BGZ$N7['<4$"[3ITZ.IV.4UML;&Q45!3]
M:M '@XJ:.8A0H/,D)N_N!>%^B)=\_/L2=O'QOS<K=%CQB4.'3;J0E)C(Q,2+
M[Q<T@  (@("]"/S]]]_&Q54/#P]R8_?NW38X\\:;;[B;N0)>"W!R<A*B,YO6
M!G.O=P/??:?%.YR?;EV[D8"KJVM</-\RK!!SJ@J0MR,NL_N<E" !(\LHHZ,Y
M97Y>_:7EMI   1   4<E\.O^7\FUNG7KTG\[M.]@<'/[CNW2^BMM25&:AH[X
M<$0YOW+BG53/#%)_K+&]KN1D3LMTU*2]/()=$  !$!!)8./&C3FY7ZQO-]>7
M^O+Q\:%)(/TC,C)2I.;\TEP][R!OA4][%!--+R#SOH/4:ET"!M%K2-FO7<$A
MN2\@Z4-(]>9RLC6-6[3P:_.6[+9A  1   3R$)#J':1!SWOOO5>C>@VC>L,/
MM5KMF-%C+%(WOH/T]/2LW^"_8F%Y&]Z(N'']^G7Z29,F31HUY"[*;9!?NFRI
M(6"3-@W#4;^:?N51Q(.2?>K4KN/KZVO1/8L"ZIE!5FS+D1$3T+*]1022")3P
M\3'10XL&B(Z2L(42$  !Y0FL7+728#1O=#0$)_JO\76@0,>>/'FR[Y=]G!]#
M=*Q<N3)_="29-N^U,9@C;;%/8CD_-+N]<.'"EO]M24^7X 1?]<P@<[G=.K]I
M,9UL3-,XC=8IH'47ILQ; L=/O-BY=1MN_'O5,(/T\O9^>^)H\3JA 01   2L
M)2#)#-*@Y/U>[Y<J5<K$ >'ZC3-(WS*^ :\&<':$SC(R)/YX>WOWZ=V'O[.T
M2'?JU*G4E%1S8BDI*906:_BMM;LVV3I5%B"MO9$@#P(@  )J(R \@)GKN7%#
M!3^:3AT[5:Q8D4?&&"![].Q1IG09<Y)AN\,B(B(D"6FD1'SWC7ZJ9XE5;?<X
M^@,"(  "]B!P[]X]]I8Y3D="=X5*XF"1(D4DT2.Y$@1(R9%"(0B   CD8P+;
MMF\C[VDK8<,&#1N9N0SIK)0R\]-//XGO*KU3%**$IH;&V:$0>?$R")#B&4(#
M"(  "#@B@<@[D<^2ZPTI]JP/V^D]>_<8IH^TE;!ITZ9-&C?A_ P;.HP264GL
M\A6.#>ALM:?_/&T.$&73W+Y]6S@^>L7(TRDJ1V=0)<G>2H=[!QFQNW-NGHM^
MMT:ILM6*-I@M')Q8R:O']X?NR,TB)NO,R_4;EWJGLUB=@ML__>U*V,:M^KYG
MZX>V_[JI@IM"$ 1   3^(R!\FL5.8S&T+5^^?)?.7?B97KAX8?]^_6&Z5/5M
M]$?<.8E6U6*U6.A5>+_(J^[=NY<M4U;D;>%8,\B;>[OF[4]TU/7;/PT6V4.A
MS9_>.+#KA?(0YT^=8*[^);2Y.+D[X:?"-FTUZJ"%BPV#YHI3B=8@  (@8!T!
M*KMJ:& Q.I+,RR^];)BET8PS+2W-.DLL::I"8+$,^M"A0P5:J5*EBOCH2+8<
M:@9Y,.+'E4R.UCB#-/RC1N?_"80B1NS@PK$&<\89I'ZOB$;;,GB^&+4"VVX:
M.DN_K\A09R"W_$X.H_$MY]?ZT_X"-4 ,!$  !$! 6@(.-(-\^-LF,WV[*FV?
MA6O+,00K^2_.7;=/'L7*;QD60  $0  $N DX4("DZ9J94;*CD]S5C)2YFQ0+
MS\IT!U9   1 ('\1L&/L,055LIFYY42A9X^)0<]YNIBKFYL8G<+;4BT)MK!7
MR9+"-4 2!$  !$! 6@(.%" 9IAF[;\5+E):VP^:TO3EN$3M&OCGN4V6LM^UA
MFBY+SK3^S-P3@S).P0H(@  (%&@"#I6DHQ^)I#,3[T?=T"?(,-JJ[_9F"K53
M<GSN[-UTY<(YREWR]2OOW_LC)4TS#[(VA,PV).F4*ENZS2RETG<5[22,@0 (
M@$"^(>!P 3+?D(.C(  "(  "JB;@4$NLJB:-SH$ "(  ".0K @B0^6JXX"P(
M@  (@(!2!%2WQ)IQ,?G"Z>RL'(^J=1BOADIA?&8G]LC1A]$Q'D6+E6W=0F'3
M, <"(  "(" M 54%R%OA,QX]N$]%7 TU<5S=W%_INUA:7CS:0B>'Y!8#-M3B
M85YMW*1RIV?G7ROF PR!  B   A(14 ]2ZSI%]8_BKF7ETM::O*-L#E2D>+7
MLRLXQ$3@S+$_E#$-*R   B   G(04$^ O'S^!!O0H^B[<E SU9F4Q&EE_^RE
M2EB'#1   1   1D(J"= 9F;JSS SN>A8#!F@L51&17%:24U)4<(Z;(  "(
M",A 0#T!LK!'$38?\_5=)659HP:G.I^R?I*:@3(0  $0  'E"*@G0-9LWI:-
MK4*UVLJP='9Q81MJ,+RO,M9A!01   1 0'("Z@F03,FW:[Y</R^@$MZ^I=[^
M4')DG K?^V1&WAA)E51;M.<(V,HX RL@  (@  +B":AJFX<!1^K9#<E)R5ZO
M#Q=/QVH-<8F7PO=6]_=W?D6AF:O5'J(!"(  "(" , (J#)#".@XI$  !$  !
M$. CH*(E5@PT"(  "(  "$A'  %2.I;0! (@  (@H"("") J&DQT!01   1
90#H"_P>L>)^PX- 9RP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>sttk-20210811_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sttk-20210811.xsd" xlink:type="simple"/>
    <context id="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001680367</identifier>
        </entity>
        <period>
            <startDate>2021-08-11</startDate>
            <endDate>2021-08-11</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV80L2ZyYWc6MjAwNTdmYzJhYTEyNDVjNmE0YzZlYzI4YzFkMWNmMmQvdGFibGU6M2NhOGM0MmUwNjhiNDBlN2JjODQ3ODAxMmVkODczYzkvdGFibGVyYW5nZTozY2E4YzQyZTA2OGI0MGU3YmM4NDc4MDEyZWQ4NzNjOV8wLTEtMS0xLTA_bc653764-7349-4eb5-b104-a163a1fc4c5b">0001680367</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV80L2ZyYWc6MjAwNTdmYzJhYTEyNDVjNmE0YzZlYzI4YzFkMWNmMmQvdGFibGU6M2NhOGM0MmUwNjhiNDBlN2JjODQ3ODAxMmVkODczYzkvdGFibGVyYW5nZTozY2E4YzQyZTA2OGI0MGU3YmM4NDc4MDEyZWQ4NzNjOV8xLTEtMS0xLTA_7e0911ac-c54d-424d-9bf5-3d35556c8d47">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81ODI_6658cf96-9158-460b-9e84-436f78ae5f59">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV8yMjU_bdac7918-b75e-45f1-bcdf-5809f6243250">2021-08-11</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81NjY_e5d97022-03e0-4349-a1b1-5ec0f6589043">Shattuck Labs, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6YzhhMjNjZmExMDBmNDNkNWJkM2Y0MjQ3NjgyZWJmODcvdGFibGVyYW5nZTpjOGEyM2NmYTEwMGY0M2Q1YmQzZjQyNDc2ODJlYmY4N18wLTAtMS0xLTA_984db547-fecd-4ccb-b3cc-99122f7e33ab">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6YzhhMjNjZmExMDBmNDNkNWJkM2Y0MjQ3NjgyZWJmODcvdGFibGVyYW5nZTpjOGEyM2NmYTEwMGY0M2Q1YmQzZjQyNDc2ODJlYmY4N18wLTEtMS0xLTA_b779ccf8-ed9d-44ec-983d-1e995ec1a110">001-39593</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6YzhhMjNjZmExMDBmNDNkNWJkM2Y0MjQ3NjgyZWJmODcvdGFibGVyYW5nZTpjOGEyM2NmYTEwMGY0M2Q1YmQzZjQyNDc2ODJlYmY4N18wLTItMS0xLTA_5e97d369-9385-4ac5-8ad7-b1a148e6a9e2">81-2575858</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81Njk_daa6f767-8c81-46d4-bf3e-732c5644b42b">500 W. 5th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81Nzc_b5d49500-eb1a-4dfe-a45d-0ba286d75814">Suite 1200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81NzE_e763a4e5-f404-453b-b2ea-de9c69b079e3">Austin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81Nzg_adb84946-298a-4e79-813b-ea297077fe82">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81NzM_0eb7512b-cf69-440d-934a-ecfcb1fcc99b">78701</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV8zNjg_4322afb5-d915-4a54-aed6-b424c64ab6b8">512</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGV4dHJlZ2lvbjoyYmY2NWUxZTYzMTA0MWY3YmZkNDMxZTI2MmNiYmQwZV81Nzk_a7629878-8f81-48b8-8800-44e74b932f5e">900-4690</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6MTVjOGE4ZGEyZDkwNDNhYWE5M2Q1NjI1ZDk1MjVhMTMvdGFibGVyYW5nZToxNWM4YThkYTJkOTA0M2FhYTkzZDU2MjVkOTUyNWExM18xLTAtMS0xLTA_6fdbe148-5734-4712-8cd6-6bea935e6ade">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6MTVjOGE4ZGEyZDkwNDNhYWE5M2Q1NjI1ZDk1MjVhMTMvdGFibGVyYW5nZToxNWM4YThkYTJkOTA0M2FhYTkzZDU2MjVkOTUyNWExM18yLTAtMS0xLTA_2fc35bb6-c267-441c-ae42-fae0f692704d">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6MTVjOGE4ZGEyZDkwNDNhYWE5M2Q1NjI1ZDk1MjVhMTMvdGFibGVyYW5nZToxNWM4YThkYTJkOTA0M2FhYTkzZDU2MjVkOTUyNWExM18zLTAtMS0xLTA_4089e080-282f-4422-8af9-8b68798ec22f">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6MTVjOGE4ZGEyZDkwNDNhYWE5M2Q1NjI1ZDk1MjVhMTMvdGFibGVyYW5nZToxNWM4YThkYTJkOTA0M2FhYTkzZDU2MjVkOTUyNWExM180LTAtMS0xLTA_84092d9a-955a-4929-9dd1-7a195e622da5">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6N2Y5NTg2NmYwMDcxNGY0Y2I4ZWQ4NzE2NTlhMGRhZjIvdGFibGVyYW5nZTo3Zjk1ODY2ZjAwNzE0ZjRjYjhlZDg3MTY1OWEwZGFmMl8xLTAtMS0xLTA_4d65a43f-5eec-40f6-816a-36941f63116a">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6N2Y5NTg2NmYwMDcxNGY0Y2I4ZWQ4NzE2NTlhMGRhZjIvdGFibGVyYW5nZTo3Zjk1ODY2ZjAwNzE0ZjRjYjhlZDg3MTY1OWEwZGFmMl8xLTEtMS0xLTA_af2e8e43-cc51-47cc-83d2-e9d537b0ad80">STTK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6N2Y5NTg2NmYwMDcxNGY0Y2I4ZWQ4NzE2NTlhMGRhZjIvdGFibGVyYW5nZTo3Zjk1ODY2ZjAwNzE0ZjRjYjhlZDg3MTY1OWEwZGFmMl8xLTItMS0xLTA_40d458a4-6e60-4842-b2c6-d165b168adeb">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6MjE3MzU4ZTY5ZmVlNGU5Yzk3NzAwNGZjNzEzNjFkNGQvdGFibGVyYW5nZToyMTczNThlNjlmZWU0ZTljOTc3MDA0ZmM3MTM2MWQ0ZF8xLTEtMS0xLTA_1f6810d8-b35b-40ac-ae12-e9b77302d5da">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i5a2965c35814496caec20f0007d0b90d_D20210811-20210811"
      id="id3VybDovL2RvY3MudjEvZG9jOjUyMTI1MjZmOWQ1NzRlZGZhYTk0NGYzZDkwNWUyZmYxL3NlYzo1MjEyNTI2ZjlkNTc0ZWRmYWE5NDRmM2Q5MDVlMmZmMV8xL2ZyYWc6MmJmNjVlMWU2MzEwNDFmN2JmZDQzMWUyNjJjYmJkMGUvdGFibGU6MjE3MzU4ZTY5ZmVlNGU5Yzk3NzAwNGZjNzEzNjFkNGQvdGFibGVyYW5nZToyMTczNThlNjlmZWU0ZTljOTc3MDA0ZmM3MTM2MWQ0ZF8yLTEtMS0xLTA_3f3bb722-04d5-4d3d-890c-a17582b912ac">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140012281431032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 11, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 11,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Shattuck Labs, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-2575858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 W. 5th Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Austin<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">900-4690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">STTK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001680367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
MZX,+4X#2MZ]<!   91$  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R=
MF%USXC84AJ^WOT+#]**=2? 'WSN$&4*2-K/9+(UITVFG%\(66!-;<B4YP+_O
MD0&;MN:8W1ML&9^71T='KR3&&ZG>=,R8(=LT$?JF%1N3?70<'<8LI;HM,R;@
MFY54*3705&M'9XK1J A*$\=WW;Z34BY:DW'Q;*XF8YF;A LV5T3G:4K5[I8E
M<G/3\EK'!R]\'1O[P)F,,[IF 3._9G,%+:=4B7C*A.92$,56-ZVI]_'6[]N
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M,_V^8616G*.7TL"IO+B-&04CLR_ ]RLIS;%AC^;E/RN3?P!02P,$%     @
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M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ ZX,+4P=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " #K@PM3FYKVUNT    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " #K@PM3F5R<(Q &  "<)P  $P
M        @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( .N#
M"U. TK>O7 0  &41   8              " @0P(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " #K@PM3GZ ;\+$"  #B#   #0
M        @ &>#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .N#"U.7BKL<
MP    !,"   +              "  7H/  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( .N#"U.JQ"(6,P$  "("   /              "  6,0  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " #K@PM3)!Z;HJT   #X 0  &@
M    @ '#$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" #K@PM399!YDAD!  #/ P  $P              @ &H$@  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  #R$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="sttk-20210811.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.shattucklabs.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="sttk-20210811.htm">sttk-20210811.htm</File>
    <File>sttk-20210811.xsd</File>
    <File>sttk-20210811_lab.xml</File>
    <File>sttk-20210811_pre.xml</File>
    <File>sttk_2q2021earningsrelease.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sttk-20210811.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "sttk-20210811.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sttk-20210811_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sttk-20210811_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sttk-20210811.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "sttk",
   "nsuri": "http://www.shattucklabs.com/20210811",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210811.htm",
      "contextRef": "i5a2965c35814496caec20f0007d0b90d_D20210811-20210811",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.shattucklabs.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sttk-20210811.htm",
      "contextRef": "i5a2965c35814496caec20f0007d0b90d_D20210811-20210811",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.shattucklabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001680367-21-000035-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001680367-21-000035-xbrl.zip
M4$L#!!0    ( .N#"U.4MJA\J14  .&0   1    <W1T:RTR,#(Q,#@Q,2YH
M=&WM/6E7XLC:W^^OR,N\=ZY]C@59*AO=[3V.H$-/$UI%'?CBJ:0J$D@(DP0!
M?_U]JA(47-%V;[]T&ZI2R[,O54^^_'<:A=(I2](@'GXM*66Y)/UWX\O_(?3W
M'WO?I5KLC2,VS*2MA)&,46D29#WIB+)T(/E)'$E'<3((3@E"XIVM>#1+@I->
M)JFRJEQJ3*J^;EK$4A@R35M%F!$7V;J.$?:PR13J^3I5UD^J*C6H1A6,;-OV
M$%:HC5Q#]9"B&+[J$]O%LKM.J[JJJ+IJ^#;53<RH3XB-L:]16]:9ZOL*G[:7
MP>Y@A\.T.@V#X>!KJ9=EHVJE,IE,RA.M'"<G%06FJ8C64M$UF"[UF[I)*'JJ
MLJ)5@B%T91PZ\^Y7!EYX0=8JO-DE*9MWGZ;!=<N ODKE[^;W?:_'(H*"89J1
MH<<NUI2AE'E+;\)S^20^75A2)4O(,/7C)"(9()2O6$>RA31E/@YE%[.+=<X'
M@88*Q]K"A-=OZJ[95*0:YWN%EX);8'-IES>CAR-2=*J&9'CRM<2&Z&"_! AF
MA&Y\B5A&)/XJ8O^,@].OI:UXF '9HO9L!&-[^=/74L:F644,5=GXU[_^]24+
MLI!MI%DV0'SKLJ4H7RKYCU\J^=!N3&<;7VAP*J79+&1?2S1(1R&958?QD,$"
M@FF5=V1)_F= *1N*/Z'= =Y) B^??YKM,?]K*="):ANZI^F6@K%M>(1YJNS+
MLFQ2V;5E>ER;+^5\325I2"(^-0NJ]2&L;[8%VTE(V!A2-OV+S4I20&%HJAW.
MW%I\^EW=.^UHS3'MUT^[.W:_U3^8-=L-I=GO1JVC7<4YVPN[.]U>ISV0G9W.
M6;<VF#A'![-NU)E^UYRP<Q9#W_K,:3?4;C\<.&U/[A[M19VCNN[4]J*FNJLW
M:X=A,^I&S4-+_JYV9YTCSVCV-R=.FT:=LV\P-KQ?.^P[45V&&6#,!NZ<;0^:
M1T[4C'9/Z<YVX.X<&$W5Z;5VFG(S.I@X_5[@U/X('?5;OU7;U5JUS6DS.ART
M:MY9YVQ0O',(<^G#;CL^ZZAU&'-WUFUOJJV=AMS<.= Z41,[-0\W:_59]V@7
M.V=.OW5H3;ZWZUES7YY^;V\>NYZA:Z:!D:EA&^20JR-7D3$BBJ$1Q?>PI[NE
M#4")8EBR9IA?*DOX?'STYBP$;T^SJAO'(2-#GX1<9%P@?A/D,.6R>#LD)Q\(
MOPOATT6$FTRV%85XR-,Q15B%?VS7UY%&-5W7#<^BV"QM;&]^WZ]?P75EF:T3
MYK.$@<A*KY%&7-174R' @1HDH52J&<B@KZ4TB$8AEW/BMU["B65)\)2G*84A
M*LMCY/-?3%JL(8W'B7@2 K9:4&!.% ^AP/E 3$B7^5- ^;,?L$02"V+7:I^M
MQE_+S'+YY8WY3\NCCP"^,9T_@1Y(LAK8&!M\45QG<5E\N>U\F?2&KO.6^?-\
MDLH2H.90/0=C94&,5T#8YQ(_!^<=9L8QA][%.X66B((AZC%N"E5-=91]G@0T
MZU456?YW2?3;^)*."%"4FU3@[?SO?) K0_$%(Q(&)\.J!Q!D"8R0$3=D\PYN
MG,#"D1>'(1FEK#K_X_-<5>4:&XF7/D<D.8'%N7&6Q5%5A[6!]9<%'@F+2<1\
M>?/%LLMROO0, )31^<Q%<UDT53)ZM<VVRK9\<[-<5L[;*F+L9-ZA@)XVRDKB
M/=@5!]/7DE:ZM/%B*]!3HO&8 ^8W6.WG$:$T&)Y494D18UQ,4A&06!'4?-)Y
M.ZPA3JI\=#Z!#\2$?!(%X:SZGW80@4APV$3:BR,R_,]Z"J816&Q)X.<=T^",
M515<YA 7/TP*\H"1!'J*#=LV0.3 :;3K-6F_O=FN[TO+!/(:U[M?WSK8:[0;
ML-A-IR;5_][Z<]/9J4M;K6:SL;_?:#DON EKM3T<;>[_V7!VVBUG7:IM@0>C
M8_OF51=LE,6CJ@&COP9,*"IGM.W67E-Z0@-T[A+FIO5+FB'3<S,D^A8Y??C]
MZ$!MGM4G3FT[ I,BZM9VS^"WF=/_UN]$WP9@+H!)<8CIG]_"KAJ>NOUXUHDZ
M*JQAVFUWSIKM3;EYU &3HCMP:DWXK:$V(R?H1+N3[J&EM&J-8\/0+<^W#60K
MNH6P(8,/RRSP837#!^^6Z;YNES8L]-=50^*U4)*Z$AT!0^_5G;:T5__1VFN_
MH A25F'>'^,D'9-A)F6QM,\\[HY*BB;%B:3H:_33:U]^[$M9C_&5CY,@"V#<
M^M3K@6W)I$TODZ!9L37\VG?!+2^^UCTVBI-,6IL_,P*V%TLSB9WR6%(BFAG]
M5'U\.;7H25&8/H(1>Y3,9K &-KQ.COT0%F(]MQM_+8$V:_8/CEU*/--6+.2:
M.D-8]Q7D>M1'NB7;OJ%B3=7ETL;F^&0,"%24=1':6UFXO;SQBNVR8ENOW'8%
M]I+2. SHZS5=57DU,^K)8U][["1(>>0Q<Z#EU^)8Q>EWCIE.;5-6521K3 ;#
M ]N(**Z"=.;)/I@GMHPU,,E[),O&WD#Z3MQT76H,O?)EKGU)FWP54EJK3PEH
M/TX 7(TDYXB72"JE(^;Q\ *5@J$49*D$^A*T2O+I?KOZ$$:/*(QNCFJ\*BS8
M>EG3U8=@0<-ES5!7PL*]AE7*BF$]R;#FO6CF)@*9TX ZFG(JN.JD7 %Z/'IT
M&U2^RV]1]*?0/PLF)<_ \6ADQD9)?,KETK)-F2LH$+5Q B:N2(KM\]Y;\7B8
M);.MF+Y-?95'[CMGO5ZS[\#*ZM-F[8_(J3D#YPCZJ!VYV=_5G/[)K'OT+6K5
MO$N1^U&_M5.?-54GZK3KD^8.]%=W%=!I9]W^[LRI>6JK]BT$/8@=A:=J-L\C
M][:%J:MC$_G,HPA[GHM<S?.0;2NJZIM,TX@+C@<+R00,_!O-TH+\'X.R<TGR
M[,1M:L]A6VT'(8/171#*'W1Z-YTNI!1-T_8\WT*,VD"GF &)6AI%"K-ML,L4
MHB@RSY(H2+-U6WL.0GU'(O@RF;;)M%&DESPA93]H=F6:;9S3K,YLDVJ&C6S-
MTA$FGHXL0DWD K5BBQG$9FIIPP)$Z*9NZ=:M1/M^#(@UH;)YZ##.>BR1^N,D
M2&F0QQ1C7QBWP:**%UV3$S(,SL3SI_?%S6M;<10%*3\@)G'](.7,]MYVV2CO
ME??+4CT:A?&,)0+-RT+FVHW?'I4I (!"YF?<^=.%!_5 )^E=BO)-2A.6IL5_
MWV$!RIL4XS\3TAD<4T(,WS1,9'D@;[%!,7)]C2%34SW=P-C%*IBYNBQ+1V5)
MSWK2?I8PEEV6R.M/F?B["5_JKX:O,^_8U2FV 1V(@;)$F/H,$:Q3)+M$M0QJ
M<A"7-O;' 2@2197E5Q1Y>V6,OP5_MI)V/!G^<F14/V:FH1',=.1C&2.L:^#=
MJHP@RFS/L%W9M)G&<R]I%@Q?CM>%/=1*?B3Q:2#.ZOYB>#HY)M2UL(T-I-H6
ML#LS;60I@"P&4#9ET_29!99R^^^K;/Y,*/H1IQD)N\'HS8:8?@9!S6.9N::N
MJ"[R?/!G,)8I.#68(.;YGJOXGF?;H#]-RY2OI"Y?<[K T,N6H3]/NF 5&U[5
MRZ;^BH-D>=:HX F>,AHE(+&"$0DE-F7>. M.>28)#'J8#5K",=^:=!:,8.>4
MW6+9OX0*?LU&0@[I)Q1OW"[83!CY]03:F=,_.<::JA+?U1&U%1Z;T3$BC!H(
M' 'L&9BXAFN!0Z"HE\79IZ?4.=]C8/$?O7CXEH/$/Z-I!L?$-, (,"UD^=Q3
MLUSXRP)' (-5@%U;4WV=E39L_HMAKV#WOT#NT\AS":]#I5P*"_% R?5!H==T
M.L'B %R[.(CR^V^6JIB?4REC(1MQ_I"&@D'6%[0, 6EV2<WD!_Y?P>&>.S<L
M0F3;<0)D7)S'2$1B%!Y)KFYAJ[Z4GUD$RN".@A22='[:[WXG,)_9RK+*6+7?
M[:&,NXCHU1_7^)GK)V5-,1[]7(4%!&/AATM"XZ&2\)G,:GR=L;?58]Y G%(F
MHU$2@V7-LR1N/)5<%L83SOV\D<L(R4)_27X0<JD7<$,[8T,*4B&+03!$XS C
M0Q:/TW FI20+4G\FWBQ>B%W8:I%7R8=<./<UAG% X@QG\S8?B"V>\/?XB8R
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M\&X[?J9>O7VQ>2=;_5<9;U_\'U!+ P04    " #K@PM3AE.9@00'   5-0
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MD@O0DCY<=F=V@W;WSF@@[*ZJKTL\\;*CHGO3<]+S\0CNAIN7V7WWVSO%N3F
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MJVD,G$%H%63XHBWD;V1@!U9*@*.+8F<EC2R"'%OX*E36\$G^F!ON=Y@'&"=
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M\J ]63PQ8JNRYH%6G%XYR*+MA7MQ?D>1XB8WPA-C(!2A,$<>1:76FL13,"W
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:+FAT;5!+!08     !0 % % !  #M3      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
